These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11443872)

  • 1. Antibody-mediated enhancement of viral disease.
    Sullivan NJ
    Curr Top Microbiol Immunol; 2001; 260():145-69. PubMed ID: 11443872
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent enhancement of viral infectivity.
    Porterfield JS
    Adv Virus Res; 1986; 31():335-55. PubMed ID: 2428214
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications.
    Takada A; Kawaoka Y
    Rev Med Virol; 2003; 13(6):387-98. PubMed ID: 14625886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent enhancement in dengue virus infections.
    Burke DS; Kliks S
    J Infect Dis; 2006 Feb; 193(4):601-3; author reply 603-4. PubMed ID: 16425141
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancing antibodies in HIV infection.
    Füst G
    Parasitology; 1997; 115 Suppl():S127-40. PubMed ID: 9571698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent enhancement of infection and the pathogenesis of viral disease.
    Morens DM
    Clin Infect Dis; 1994 Sep; 19(3):500-12. PubMed ID: 7811870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue virus infection-enhancing and neutralizing antibody balance in children of the Philippines and Indonesia.
    Yamanaka A; Tabuchi Y; Mulyatno KC; Susilowati H; Hendrianto E; Soegijanto S; Konishi E
    Microbes Infect; 2012 Nov; 14(13):1152-9. PubMed ID: 22841680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.
    Littaua R; Kurane I; Ennis FA
    J Immunol; 1990 Apr; 144(8):3183-6. PubMed ID: 2139079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness.
    Kliks S
    AIDS Res Hum Retroviruses; 1990 Aug; 6(8):993-8. PubMed ID: 2223245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralizing antiviral antibody responses.
    Zinkernagel RM; LaMarre A; Ciurea A; Hunziker L; Ochsenbein AF; McCoy KD; Fehr T; Bachmann MF; Kalinke U; Hengartner H
    Adv Immunol; 2001; 79():1-53. PubMed ID: 11680006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antibodies in controlling dengue virus infection.
    van der Schaar HM; Wilschut JC; Smit JM
    Immunobiology; 2009; 214(7):613-29. PubMed ID: 19261353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we find a possible structural explanation for antibody-dependent enhancement of dengue virus infection resulting in hemorrhagic fever?
    Mikita CP; Padlan EA
    Med Hypotheses; 2016 Mar; 88():49-52. PubMed ID: 26880637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.
    Ramakrishnan B; Viswanathan K; Tharakaraman K; Dančík V; Raman R; Babcock GJ; Shriver Z; Sasisekharan R
    Trends Microbiol; 2016 Dec; 24(12):933-943. PubMed ID: 27751627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production.
    Yang KD; Yeh WT; Yang MY; Chen RF; Shaio MF
    J Med Virol; 2001 Feb; 63(2):150-7. PubMed ID: 11170052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
    Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
    PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to dengue fever--the good, the bad, and the ugly?
    Schmidt AC
    N Engl J Med; 2010 Jul; 363(5):484-7. PubMed ID: 20818870
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design.
    Falconar AK
    Clin Vaccine Immunol; 2007 May; 14(5):493-504. PubMed ID: 17329445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.